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The cell surface mucin MUC1 is an important host factor limiting Helicobacter pylori
(H. pylori) pathogenesis in both humans and mice by providing a protective barrier and
modulating mucosal epithelial and leukocyte responses. The aim of this study was to
establish the time-course of molecular events in MUC1-modulated gene expression
profiles in response to H. pylori infection in wild type (WT) and MUC1-deficient mice
using microarray-determined mRNA expression, gene network analysis and Ingenuity
Pathway Analysis (IPA). A time-course over the first 72 h of infection showed significantly
higher mucosal loads of bacteria at 8 h of infection inMuc1−/− mice compared with WT,
confirming its importance in the early stages of infection (P= 0.0003). Microarray analysis
revealed 266 differentially expressed genes at one or more time-points over 72 h in the
gastric mucosa of Muc1−/− mice compared with WT control using a threshold of 2-fold
change. The SPINK1 pancreatic cancer canonical pathway was strongly inhibited in
Muc1−/− mice compared with WT at sham and 8 h infection (P= 6.08E-14 and P= 2.25
E-19, respectively) but potently activated at 24 and 72 h post-infection (P = 1.38E-22
and P = 5.87E-13, respectively). The changes in this pathway are reflective of higher
expression of genes mediating digestion and absorption of lipids, carbohydrates, and
proteins at sham and 8 h infection in the absence of MUC1, but that this transcriptional
signature is highly down regulated as infection progresses in the absence of MUC1.
UninfectedMuc1−/− gastric tissue was highly enriched for expression of factors involved
in lipid metabolism and 8 h infection further activated this network compared with WT.
As infection progressed, a network of antimicrobial and anti-inflammatory response
genes was more highly activated in Muc1−/− than WT mice. Key target genes identified
by time-course microarrays were independently validated using RT-qPCR. These results
highlight the dynamic interplay between the host and H. pylori, and the role of MUC1
in host defense, and provide a general picture of changes in cellular gene expression
modulated by MUC1 in a time-dependent manner in response to H. pylori infection.
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INTRODUCTION
Chronic infection with the gram-negative bacterium
Helicobacter pylori (H. pylori) induces a chronic gastritis in
susceptible individuals, which can lead to gastric ulcers, and
adenocarcinoma, a malignancy of the glandular epithelium of
the stomach. Despite declining prevalence of infection in the
Western world, gastric cancer remains one of the most common
and deadly cancers worldwide, and is the 5th most common
neoplasm and the 3rd most deadly cancer, with an estimated
783,000 deaths in 2018 (Rawla and Barsouk, 2019). Only a
fraction of individuals infected with H. pylori will develop these
associated pathologies, and this variability is attributed to a
mixture of environmental, bacterial, and host factors.
One host factor linked with susceptibility to Helicobacter-
associated gastritis and gastric cancer is allelic variation in
the gene that encodes the MUC1 mucin. MUC1 cell surface-
mucin is densely present on the apical membrane of most
mucosal epithelial cells, including the gastric mucosa where it
is very highly expressed. MUC1 is a dominant constituent of
the glycocalyx (McGuckin et al., 2011; Sheng et al., 2012), with
the full-length form of MUC1 consisting of two non-covalently-
bound subunits: a long N-terminal extracellular domain and a
short C-terminal cytoplasmic domain. MUC1 is also expressed
by some leukocytes, including monocyte/macrophages, dendritic
cells, and activated T cells (Wykes et al., 2002). Several
epidemiologic studies have linked MUC1 polymorphisms
in humans with susceptibility to H. pylori-induced disease
(Carvalho et al., 1997; Vinall et al., 2002), suggesting a direct effect
of MUC1 polymorphisms on the development of Helicobacter-
associated pathology. We have shown that mice deficient in
MUC1 are more susceptible to infection by H. pylori and that
differences emerge very early in infection and are sustained, with
characteristically more severe chronic inflammation (McGuckin
et al., 2007). Mechanistically, we have shown that MUC1 in
gastric epithelial cells limits H. pylori infection both by steric
hindrance and by acting as a releasable decoy (Linden et al.,
2009), and that MUC1 in macrophages suppresses inflammation
by negatively regulating the inflammasome (Ng et al., 2016).
However, the molecular network pathway by which this mucin
limits bacterial pathogenesis has not been fully elucidated, and
differences in the very early stages of infection have not been
explored. Therefore, the aim of this study was to elucidate the
time-course of molecular events and dynamic networks in gastric
tissue fromMuc1−/− and wild type (WT) mice in response to the
very early stages of H. pylori infection, and to validate key target
genes involved in the molecular changes in gastric tissue during
H. pylori infection.
MATERIALS AND METHODS
H. pylori Culture
H. pylori strain SS1 (Lee et al., 1997), was initially cultured
on horse blood agar plates [Blood Agar Base No. 2, 0.02%
Amphostat, and Skirrow’s Selective Supplements [Oxoid,
Basingstoke, United Kingdom] and 5% horse blood [Biolab,
Clayton, Australia]] in an anaerobic jar with a microaerophilic
gas generating kit (Oxoid) for 2 days at 37◦C. Prior to infection
of mice, H. pylori were cultured in brain heart infusion broth
(BHI; Oxoid) containing 5% horse serum (Sigma, Castle
Hill, Australia), 0.02% Amphostat, and Skirrow’s Selective
Supplements under microaerophilic conditions for 24 h at 37◦C.
Murine Infection Experiments
Muc1−/− [derived and kindly provided by Sandra Gendler,
Mayo Clinic Spicer et al., 1995] and wild-type (WT) mice,
all on a 129/SvJ background, were bred within the Veterinary
Science animal house, University of Melbourne, and genotyped
as described (Spicer et al., 1995). All experiments involved
age-matched female mice and were performed under Animal
Ethics Committee approval (University of Melbourne; AEECNo.
06205). Mice were infected intragastrically once with 107 H.
pylori SS1 suspended in 0.1mL BHI and groups (n = 3 of each
genotype) were euthanased after 8, 24, and 72 h for collection
of gastric tissues to determine bacterial abundance and gastric
gene expression. Control uninfected (sham) mice were mock-
infected with 0.1mL sterile BHI and sampled after 8, 24, and 72 h
mock-infection (n= 3 of each genotype).
Determination of Infection Levels
H. pylori infection levels within mouse gastric tissues were
quantified by colony-forming assay. Briefly, stomachs were
opened along the inner curvature and bisected longitudinally.
One half was placed in BHI and homogenized (GmbH Polytron
homogeniser, Kinematica, Switzerland) and the other half rapidly
frozen for RNA extraction. Ten-fold serial dilutions were
prepared in BHI broth and aliquots spread over GSSA
selective agar plates [Blood Agar Base No. 2 with 5%
horse blood, vancomycin (12 mg/mL), polymyxin B (0.40
mg/mL), bacitracin (24 mg/mL), nalidixic acid (1.3 mg/mL),
and amphotericin B (3.75 mg/mL), all from Sigma]. After 5
days culture as above, colonies were counted, and the number
of colony-forming units was calculated per stomach (McGuckin
et al., 2007). Colonies were confirmed to beH. pylori by the rapid
urease test as previously described (Sutton et al., 2000).
RNA Preparation and Quality Control
RNA was extracted from each longitudinally bisected half
stomach of each mouse using Trizol (Invitrogen) and further
purified on RNeasy columns (Qiagen). RNA integrity (RNA
integrity number >8) was verified using a Bio-analyzer
(Agilent) and RNA was stored at −70◦C prior to further
analysis by microarray and reverse-transcription-quantitative
PCR (RT-qPCR).
Time-Course Microarray Assays
Equal quantities of RNA from mice of the same genotype and
time point were pooled for microarray assays. For sham-infected
mice, equal quantities of RNA from mice of the same genotype
and all three time points were pooled as control uninfected mice.
Samples were labeled for GeneChip analysis using the One-Cycle
Target Labeling and Control Reagents (Affymetrix). The gene
expression array used was the Affymetrix Mouse Gene 1.0 ST
array. All steps of target labeling, hybridization, and scanning
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were performed according to the manufacturer’s protocol. The
entire microarray dataset is available in Supplementary Table 1.
Molecular Network Analysis
We used several gene ontology-based databases-to examine
expression of genes across the time course of response to
infection as follows;
Ingenuity Knowledge Base Network Analysis
Ingenuity Knowledge Base network analysis was conducted
using Ingenuity Pathway Analysis (IPA) which is based on the
QIAGEN Knowledge Base (QIAGEN Inc., https://digitalinsights.
qiagen.com/products-overview/discovery-insights-portfolio/
analysis-and-visualization/qiagen-ipa/), a large repository
of biological interactions between proteins, RNAs, genes,
isoforms, metabolites, complexes, cells, tissues, drugs and
diseases, manually curated by experts based on over 3.58 million
published studies. The Knowledge Base includes biological
interaction data on 19,600 human and 14,700 mouse genes. For
each time-point, IPA was used to construct molecular networks
of direct physical, transcriptional and enzymatic interactions.
Genes identified as differentially expressed were overlaid onto
the interactome. Focus genes, which had direct interactions
with other genes in IPA, were identified. For each focus gene,
the specificity of connections was calculated by the percentage
of its connections to other significant genes. Each network
was constrained to a maximum of 35 genes. Network scores
were calculated based on statistical likelihood (Calvano et al.,
2005). The score indicates the likelihood that the assembly of a
set of focus genes in a network could not be explained by random
chance alone. For each time-point, networks with a statistical
likelihood score above 30 are presented.
Graphia Pro 1.4 Network Analysis
The network analysis tool Graphia Pro 1.4 (formerly BioLayout
Express3D; http://biolayout.org.) (Theocharidis et al., 2009) was
used to examine expression of genes across the time course of
response to infection. Graphia Pro 1.4 clusters data based on
similarity of gene expression pattern with nodes representing a
data point and edges the relation between nodes. The results were
filtered to remove genes with low dynamic range. 6016 genes
where themaximum value across all samples was at least 1.5 times
the minimum value across all samples were included in the final
analysis. In a sample-to-sample analysis (similar to a principal
components analysis) nodes represent samples and the network
layout shows the similarity of samples based on the expression
of all genes in the sample. A gene-to-gene analysis generates a
gene coexpression network (GCN) (Wolfe et al., 2005) in which
nodes represent genes and edges the correlation between them
at or above the chosen threshold. The network layout shows the
similarity of gene expression patterns across all samples. The
Markov clustering algorithm (MCL) (van Dongen and Abreu-
Goodger, 2012) identified groups of highly connected genes
within the elements of the network. The inflation value was set at
1.7 to control the granularity of the clusters. GO term enrichment
was assessed using Database for Annotation, Visualization
and Integrated Discovery (DAVID v6.8; http://david.ncifcrf.gov)
(Huang da et al., 2009a,b). Gene Annotation Tool to Help
Explain Relationships (GATHER; https://changlab.uth.tmc.edu/
gather/) (Chang and Nevins, 2006) and PANTHER (version of
3 January 2020; http://geneontology.org/) (Mi et al., 2019a,b).
Mus musculus was used as the reference genome. GO terms
were selected for biological processes (GOTERM_BP_DIRECT),
cellular components (GOTERM_CC_DIRECT), and molecular
function (GOTERM_MF_DIRECT).
RT-qPCR Validation of Microarray
To validate microarray data, a selection of the most highly
differentially expressed genes between Muc1−/− mice and WT
mice were measured independently by RT-qPCR using the
same individual RNA samples. Total RNA (1 µg) from each
individual sample was used for first strand cDNA synthesis using
SuperScriptTM III reverse transcriptase (Life Technologies)
following the manufacturer’s instructions. Real-time PCR was
performed on a Rotor-Gene 3000 cycler (Qiagen) by using
SYBR R© Green I fluorescence (Life Technologies). The cycling
conditions were: denaturation for 10min at 95◦C, followed by
40 amplification cycles of 20 s of denaturation at 94◦C, 30 s of
annealing at 60◦C, and 30 s of extension at 72◦C. To confirm the
specificity of the amplified DNA, a melting curve was determined
at the end of each run. The reaction efficiency was determined
with a dilution series of cDNA containing the PCR products.
Expression of the target genes was normalized to that of Actb
(encoding β-actin) and the results presented as their ratios
(arbitrary units). Control experiments were also performed to
ensure that housekeeping gene expression was not differentially
regulated under the experimental conditions employed.
The primers used for PCR were designed from Primer
Bank (https://www.ncbi.nlm.nih.gov/tools/primer-blast/index.
cgi) or using Oligoperfect Designer (Life Technologies), and
their sequences to amplify the target genes are shown in
Supplementary Table 2.
Statistical Analysis
For microarray studies, statistical analysis was performed on the
R platform using the limma package from Bioconductor. The
False Discovery Rate (FDR) method and Fisher’s Exact Test were
used with a cut off for statistical significance of P-value of <
0.05 and a fold expression change of 2. For the remainder of the
study, statistical analyses were performed using Prism Software
v5 (Graphpad) by using ordinary one-way ANOVA and post-hoc
testing. No data were excluded from any analyses. The statistical
test used and the sample sizes for individual analyses are provided
within the figure legends.
RESULTS
H. pylori Colonization Is Elevated Very
Early in Infection in Muc1-/- Mice
In wild type mice H. pylori colonization increased progressively
over the first 3 days of infection (Figure 1). Consistent with our
previous finding of higher H. pylori colonization in Muc1−/−
mice 24 h after infection, we found thatMuc1−/− mice displayed
∼10-fold greater levels of H. pylori colonization in the stomach
compared with wild-type (WT)mice as early as 8 h post-infection
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FIGURE 1 | H. pylori colonization levels are elevated in Muc1−/− mice compared with wild-type (WT) controls. WT or Muc1−/− mice were infected with a single
challenge of H pylori-SS1. At each time point, stomachs were removed, and bacterial colonization was determined by colony-forming assay. Statistics: Muc1−/− vs.
wild-type controls at each time point (Ordinary one-way ANOVA corrected for multiple comparisons by controlling the False Discovery Rate (FDR) using “Two-stage
step-up method of Benjamini, Krieger, and Yekutieli;” n = 3, ***p < 0.001).
(P = 0.0003), consistent with a deficit in pre-existing or rapidly-
induced innate defense. The higher CFU bacterial burden in the
Muc1−/− mice persisted, being 2.5- and 2.8-fold higher at 24 and
72 h post-infection (Figure 1).
Identification and Categorization of
Differentially Expressed Genes in the
Gastric Tissue of Muc1−/− Mice
To better understand the molecular mechanism by which MUC1
mediates the inhibition of gastric H. pylori colonization, we
applied a microarray approach to examine the effect of Muc1
gene ablation on gastric gene expression in the absence of
infection. We identified 183 transcripts that were differentially
expressed (using a threshold of 2-fold change) in the gastric
mucosa of uninfected Muc1−/− mice (Figure 2A), and the top
10 differentially expressed genes are shown in Table 1. We
further categorized the differentially expressed genes into specific
functional groups according to gene ontology. Ingenuity Pathway
Analysis (IPA) Entrez gene ontology annotation was used to
determine the regulator effect network of MUC1-regulated genes
(Figure 3) and the top regulators with consistence score 4.536
were Hinf1a, Hinf4a, and Sox2 (Figure 3, Table 2). In line with
the known functions of these upstream regulators, we found
that their target genes in our data set were all increased in
expression in Muc1−/− gastric tissue, including Fabp2, Fabp1,
Alb, Abcc2, Mttp, Abcg5, and Apoc3 (Figure 3, genes with >4.5-
fold changes are highlighted in bold). Increased expression
of these genes is likely to lead to increased transport and
metabolism of lipids (Figure 3, Table 2). Correspondingly, the
top score (53) for network functions was attributed to digestive
system development and function, humoral immune responses
and organ development. This was followed by a score of 48
for network functions involved in lipid metabolism, molecular
transport, and small molecule biochemistry (Table 3). These
findings indicate that MUC1 modulates a lipid metabolic gene
network, which is consistent with previous findings that MUC1
is a novel metabolic master regulator in human epithelial cancer
cells (Mehla and Singh, 2014). In Muc1 deficiency, other mucin
genes including Muc13, Muc2, and Muc3 were increased in
expression in gastric tissues (Figure 4), although, given the other
changes in gene expression and the differences in colonization,
this was clearly unable to compensate functionally for loss
ofMuc1.
Differences in Activation of Molecular
Networks Between WT and Muc1−/− Mice
in Response to H. pylori Infection
Next a transcriptomic analysis was performed at 8, 24, and 72 h
post-infection. For this purpose, we analyzed each time point
individually, as well as in various combinations. A comparative
analysis using a threshold of 2-fold difference identified a total
of 174 differentially expressed (DE) genes in WT and 326 in
Muc1−/− mice in response to infection (Figures 2B,C). The
number of DE genes was higher inMuc1−/− mice thanWTmice
at 8 h post infection (Figures 2B,C); the higher number of DE
genes could be a consequence of the higher colonization levels of
H. pylori in Muc1−/− mice. At 24 h infection, there were fewer
up-regulated genes (20) in Muc1−/− compared to WT gastric
mucosa (80), despite the higher colonization levels of H. pylori
(Figures 2B,C). A similar trend was observed for up-regulated
genes at 72 h infection. In contrast, Muc1−/− mice showed a
greater number of down-regulated genes (173) than WT (20)
after 24 h infection, and the number of down-regulated genes
surpassed the number of up-regulated genes throughout the time
course in Muc1−/− mice (Figures 2B,C). A list of the top 10 DE
genes is provided in Table 1. The number of DE genes at each
time point in comparison to uninfected controls is illustrated in
Figures 2B,C. The number of DE genes at each time point in the
gastric tissue of Muc1−/− compared with WT mice is illustrated
in Figure 2A.
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FIGURE 2 | Differentially expressed (DE) genes in the gastric tissues across different time points of H. pylori infection. Control uninfected mice were sham-infected
with 0.1mL BHI and sampled after 8, 24, and 72 h mock-infection. Equal quantities of RNA from mice of the same genotype from the three time points were pooled
as a single sham control for each of 8, 24, and 72 H. pylori infection. (A) DE genes between Muc1−/− vs. wild type (WT) mice. (B) DE genes occurring in WT gastric
tissues in response to H. pylori infection over the course of infection. (C) DE genes occurring in Muc1−/− gastric tissues in response to H. pylori infection over the
course of infection.
Pathway and Network Functional
Categories
In this section, rather than discussing genes individually, we have
grouped differentially regulated genes into canonical pathways
and associated network functions, identified the upstream factors
likely to drive the differentially expressed genes in the network,
and focused on the most highly statistically significant changes in
the pathway and network.
Temporal Changes in the SPINK 1
Pancreatic Cancer Pathway in WT and
Muc1−/− Mice in Response to H. pylori
Infection
In uninfected mice and at 8 h post-infection, there was
significantly inhibition of the Serine Protease Inhibitor Kazal type
1 (SPINK1) pancreatic cancer pathway in the gastric tissue of
Muc1−/− mice compared with WT mice uninfected or at 8 h
post-infection (P = 6.08E-14 and P = 2.25E-19, respectively,
Figure 5), but at 24 and 72 h post-infection, we detected a strong
activation of this pathway inMuc1−/− mice (P= 1.38E-22 and P
= 5.87E-13, respectively, Figure 5). The main physiological role
of SPINK1 is to serve as a first line inhibitor of trypsin in the event
of premature trypsinogen activation (Supplementary Figure 1).
In addition, severe infections and tissue destruction cause
elevation of SPINK1 in serum and urine, suggesting that it
is an acute phase protein of the immune system. SPINK1 is
highly expressed by the mucus-producing cells of the normal
gastric mucosa and has been hypothesized to suppress proteolytic
digestion of secreted mucus and promote gastric healing after
injury (Marchbank et al., 1996, 1998; Konturek et al., 1998). In
mouse, the homologous gene is designated Spink3 (Wang andXu,
2010).
The significant change in expression of genes related
to the SPINK1 pathway included genes encoding proteins
involved with digestion, absorption and secretion. Examples
include chymotrypsin like elastase family (Cea1, Cela3b),
carboxypeptidase (members Cpa1, Cpa2, Cpb1), chymotrypsin
(members Ctrb2, Ctrc, Ctrl), Kallikrein related peptidase
3 (Klk3), and serine protease (Prss2, Prss3) (Table 4 and
Supplementary Figure 2). In WT mice, the focal genes in
the SPINK1 pathway were up-regulated most at 24 h post-
infection and appeared to be switched off and were no longer
differentially expressed at 72 h infection (Table 4), whereas in
Muc1−/− mice, the focal genes were up-regulated as early
as 8 h after infection and their expression levels switched to
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TABLE 1 | Differentially expressed 10 top genes in the Gastric Muc1−/− vs WT (KO/WT) or 72 h infection vs Sham (72h/0h) in WT or Muc1−/− (KO).
Sham (KO/WT) 8h (KO/WT) 24h (KO/WT) 72h (KO/WT) WT (72 h/0 h) KO (72 h/0 h)
Up
molecules
Expr log
ratio
Entrez gene name Up molecules Expr log
ratio
Entrez gene
name
Up
molecules
Expr log
ratio
Entrez gene
name
Up
molecules
Expr log
ratio
Entrez gene
name
Up
molecules
Expr log
ratio
Entrez gene
name
Up molecules Expr log
ratio
Entrez gene
name
SI 3.165 Sucrase
-isomaltase
CPB1 3.9 Carboxypeptidase B1 SLFN12L 2.69 Schlafen family
member 12 like
ALB 3.67 Albumin SI 3.65 Sucrase
-isomaltase
HSPA1A/1B 1.75 Heat shock
protein family A
(Hsp70) member
1A
SLC13A1 2.658 Solute carrier family
13 member 1
REG1B 3.8 Regenerating family
member 1 beta
Csprs 2.42 Component of
Sp100-rs
Csprs 2.16 Component of
Sp100-rs
SLC13A1 2.48 Solute carrier family
13 member 1
Csprs 1.55 Component of
Sp100-rs
CYP3A11 2.584 Cytochrome P450,
family 3, subfamily a,
polypeptide 11
CPA2 3.8 Carboxypeptidase A2 IFI44 2.12 Interferon induced
protein 44
IDO1 1.99 Indoleamine
2,3-dioxygenase 1
CPS1 2.47 Carbamoyl-
phosphate
synthetase 1
IDO1 1.47 Indoleamine
2,3-dioxygenase
1
SLC26A3 2.554 Solute carrier family
26 member 3
CPA1 3.7 Carboxypeptidase A1 IFIT1B 1.75 Interferon induced
protein with
tetratricopeptide
repeats 1B
TRDN 1.9 Triadin CDH17 2.43 Cadherin 17 Gm5431 1.28
CPS1 2.553 Carbamoyl-
phosphate
synthetase 1
CTRL1 3.7 Chymotrypsin like 1 RSAD2 1.64 Radical
S-adenosyl
methionine
domain containing
2
FGG 1.76 Fibrinogen gamma
chain
MGAM 2.35 Maltase-
glucoamylase
HBA1/HAA2 1.24 Hemoglobin
subunit alpha 2
CDH17 2.465 Cadherin 17 ALB 3.5 Albumin Trim30a/d 1.6 Tripartite
motif-containing
30A
SERPINA1 1.72 Serpin family A
member 1
SLC26A3 2.31 Solute carrier family
26 member 3
Trav8-2 1.2 T-cell receptor
alpha variable
8-2
MGAM 2.4 Maltase-
glucoamylase
CELA3B 3.5 Chymotrypsin like elastase
3B
USP18 1.58 Ubiquitin specific
peptidase 18
IFIT3 1.65 Interferon induced
protein with
tetratricopeptide
repeats 3
Igkv9-120 2.22 Immunoglobulin
kappa chain
variable 9-120
Olfr1274-ps 1.17 Olfactory
receptor 1506
ALB 2.4 Albumin PNLIP 3.4 Pancreatic lipase Slfn2 1.55 Schlafen 2 Svs3a/Svs3b 1.6 Seminal vesicle
secretory protein 3A
ALPP 2.198 Alkaline
phosphatase,
placental
Igkv4-55 1.16 Immunoglobulin
kappa chain
variable 4-55
CLCA4 2.3 Chloride channel
accessory 4
2210010C04Rik 3.4 RIKEN cDNA
2210010C04 gene
LOC68395 1.55 Histocompatibility
2, Q region locus
6-like
Trim30a/d 1.59 Tripartite
motif-containing 30A
CLCA4 2.14 Chloride channel
accessory 4
FGG 1.15 Fibrinogen
gamma chain
201010
6E10Rik
2.2 CTRB2 3.4 chymotrypsinogen B2 DHX58 1.53 DExH-box
helicase 58
Gm5662 1.57 Muc3 2.12 Mucin 3,
transmembrane
AHSG 1.13 Alpha 2-HS
glycoprotein
Down
molecules
Expr log
ratio
Entrez gene name Down
molecules
Expr log
ratio
Entrez gene name Down
molecules
Expr log
ratio
Entrez gene
name
Down
molecules
Expr log
ratio
Entrez gene name Down
molecules
Expr log
ratio
Entrez gene
name
Down
molecules
Expr log
ratio
Entrez gene
name
Muc1 3.9 Mucin 1,
transmembrane
Muc1 3.96 Mucin 1, transmembrane CPA1 3.94 Carboxypeptidase
A1
CTRB2 4.27 Chymotrypsinogen
B2
Olfr960 1.39 Olfactory receptor
960
PNLIP 5.68 Pancreatic lipase
Defb4 1.7 Defensin beta 4 UXT 1.61 Ubiquitously expressed
prefoldin like chaperone
CPA2 3.898 Carboxypeptidase
A2
CPB1 3.76 Carboxypeptidase
B1
DGLUCY 1.36 D-glutamate
cyclase
CPB1 5.45 Carboxypeptidase
B1
Olfr591 1.6 Olfactory receptor
591
Gm10573 1.52 Palmitoyl-protein
thioesterase 1
pseudogene
CPB1 3.856 Carboxypeptidase
B1
PNLIP 3.76 Pancreatic lipase Olfr591 1.36 Olfactory
receptor591
CTRB2 5.45 Chymotrypsinogen
B2
Acnat 1.6 Acyl-coenzyme A
amino acid
N-acyltransferase 2
27000
79J08Rik
1.25 PNLIP 3.8 Pancreatic lipase Muc1 3.52 Mucin 1,
transmembrane
Acnat1/2 1.33 Acyl-coenzyme A
amino acid
N-acyltransferase 2
CPA1 5.16 Carboxypeptidase
A1
1700010D01
Rik/Gm5941
1.5 impdh2 1.14 Inosine monophosphate
dehydrogenase 2
221001
0C04Rik
3.5 CPA1 3.48 Carboxypeptidase
A1
OR5K1 1.31 Olfactory receptor
family 5 subfamily K
member 1
221001
0C04Rik
5.05
GJD2 1.5 Gap junction protein
delta 2
Elobl 1.13 Elongin B-like CTRL 3.49 Chymotrypsin like
1
221001
0C04Rik
3.35 Olfr469 1.31 Olfactory receptor
469
CTRL 4.5 Chymotrypsin
like 1
Cym 1.5 Chymosin Eppin 1.07 Epididymal peptidase
inhibitor
Muc1 3.48 Mucin 1,
transmembrane
CTRL 3.22 Chymotrypsin like 1 Olfr517 1.28 Olfactory receptor
517
CPA2 4.41 Carboxypeptidase
A2
TRDN 1.4 Triadin ZNF14 1.05 Zinc finger protein 14 CELA3b 3.47 Chymotrypsin like
elastase 3B
CPA2 2.796 Carboxypeptidase
A2
MRGPRX3 1.22 MAS related GPR
family member X3
CEL 3.64 Carboxyl ester
lipase
Zfp947/Zfp995 1.3 Zinc finger protein
995
SRGAP2 1.05 SLIT-ROBO Rho GTPase
activating protein 2
CTRB2 3.44 Chymotrypsinogen
B2
CEL 2.2 Carboxyl ester lipase IDO1 1.21 Indoleamine
2,3-dioxygenase 1
CELA3b 3.43 Chymotrypsin
like elastase 3B
Olfr1274 1.3 Olfactory receptor
1274
Psg18 1.01 Pregnancy specific
glycoprotein 18
CEL 3.21 Carboxyl ester
lipase
CELA3b 1.88 Chymotrypsin like
elastase 3B
Klra7 1.2 Killer cell lectin-like
receptor, subfamily
A, member 4
PRSS2 3.01 Serine protease
2
Citrate transport; ion transport; sodium ion transport; succinate transmembrane transport; sulfate transport; transmembrane transport. Number in green indicates decreased expression and red indicates increased expression.
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Sheng et al. Muc1-modulated Gene Expression in Infection
FIGURE 3 | IPA regulator effect networks analysis of differentially expressed (DE) genes between Muc1−/− vs. wild type (WT) gastric tissues before infection (The
highest Consistency Score of regulator effect networks is shown). Upstream regulators are located at the top of the network, target genes are in the middle of network
and predicated disease or function in the bottom of network. Log ratio fold changes of DE genes in our data set is showed underneath each gene (red color symbol
indicates increased expression). The concept of Regulator Effects in IPA is that The Regulator Effects algorithm connects upstream regulators, dataset molecules and
downstream functions or diseases affected in your dataset to generate a hypothesis that can explain how the activation or inhibition of an upstream regulator affects
the downstream target molecule expression and the impact of the molecular expression on functions and diseases. The algorithm goes through one or more iterations
to merge upstream and downstream results from the Upstream Regulator. The networks are merged only if the overlap of targets has possible statistical significance
(Fisher’s Exact Test p-value of <0.05). For each network, a Consistency Score is calculated that rewards for paths from regulator->target->disease or function that
are consistent. Higher scoring hypotheses are those with more consistent causal paths represented by a high Consistency Score.
4–8-fold decreased expression toward 24 h and continuing to
be further down-regulated at 72 h post-infection (most of the
genes were decreased in expression by 8–32-fold, Table 4). In
addition, there was higher expression of Spink3 in Muc1−/−
mice compared with WT mice at sham and 8 h infection,
but Spink3 was downregulated at 24 and 72 h post-infection
(Supplementary Figure 4).
Lipid Metabolism and Transport of
Molecules
Consistent with observation of MUC1-suppressed lipid
metabolism in uninfected mice, 8 h infection further induced
expression of a wide range of lipid transporters in the gastric
tissue of Muc1−/− mice compared with WT (Figure 6). The
IPA regulator effect analysis revealed that the categories most
impacted by MUC1 deficiency were fatty acid metabolism, lipid
conversion and metabolism of vitamin with consistence score
= 16,028, followed by transport molecule (Table 2). In addition
to increased expression of the genes leading to activated fatty
acid metabolism that we observed in the uninfected mucosa
(Alb, Abcc2, Mttp, Apoc3, Fabp2, Fabp1), we also observed
the increased expression of genes involved in the conversion
of lipid and metabolism of vitamins (Cxcl3, Apoa2, Scd, and
Vdr) and cytochrome P450 members (Cyp2c8, Cyp2c9, Cyp2e1)
(Figure 6). For example, stearoyl-coA desaturase (Scd) is
an endoplasmic reticulum (ER) enzyme that catalyzes the
biosynthesis of monounsaturated fatty acids from saturated
fatty acids. Cytochrome P450 encompasses a family of enzymes
which oxidize steroids, fatty acids, and xenobiotics, and are
important for the clearance of various compounds, as well as
for hormone synthesis and breakdown. The expression of these
genes is regulated by nuclear hormone receptors of the pregnane
X receptor (PXR) family (Figure 6).
Some of the up-regulated genes in the fatty acid metabolism
function category were also assigned to the transport molecule
category, such as Fabp1, Scd, and Cxcl3 plus additional genes
Slc2a2, Vdr, Fabp2 and microsomal triglyceride transfer protein
gene (Mttp) (Figure 7). IPA indicated that expression of this set
of genes is likely to be controlled by PPARG at 8 h post-infection
(Figure 7). In addition, higher expression of solute carrier family
genes (Slc13a1, Slc26a3, Slc2a2, Slc40a1, Slc5a1, and Slc6a19) was
seen in the gastric tissue of Muc1−/− mice compared with WT
at sham and 8 h infection (Table 5). This family of genes plays
a pivotal role in transport of a wide variety of solutes, including
glucose and amino acids. However, H. pylori infection resulted
in ∼2–6-fold induction of most of these genes in WT at 24 h,
vs. a ∼2-fold decreased expression in Muc1−/− gastric tissues
(Table 5), and a similar trend was seen at 72 h infection (Table 5).
Antimicrobial Response and Inflammatory
Response
One of the hallmarks of H. pylori colonization is the induction
of a strong local antimicrobial and proinflammatory response by
the infected epithelium. This initiates the mucosal infiltration of
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TABLE 2 | Gastric Muc1−/− vs. WT (KO/WT) regulator effects* at different time points.
Time Consistency
score
Node
total
Regulator
total
Regulators Target
total
Target molecules in dataset Diseases and functions
Sham (KO/WT) 4.536 11 3 HNF1A, HNF4A, SOX2 7 ABCC2, ABCG5, ALB, Apoc3,
FABP1, FABP2, MTTP
Transport of lipid
8 h (KO/WT) 16.028 30 7 FOXA2, HNF1A, HNF4A,
Ncoa-Nr1i2-Rxra, Ncoa-Nr1i3-Rxra,
OSM, PXR ligand-PXR-Retinoic
acid-RXRα
18 ABCC2, ALB, APOA4, APOC2,
Apoc3, CXCL3, CYP2C8,
CYP2C9, CYP2E1, CYP3A5,
FABP1, FABP2, MTTP, MUC2,
SCD, SLC5A1, SLPI, VDR
Abnormality of large
intestine, conversion of lipid,
enteritis, fatty acid
metabolism, metabolism of
vitamin
8 h (KO/WT) 15.718 40 8 FOXA2, miR-12201-5p (and other
miRNAs w/seed GGAAGGA),
miR-1293 (and other miRNAs w/seed
GGGUGGU), Ncoa-Nr1i2-Rxra,
Ncoa-Nr1i3-Rxra,
NCOR-LXR-Oxysterol-RXR-9 cis RA,
PPARGC1A, PXR
ligand-PXR-Retinoic acid-RXRα
24 ABCC2, ADA, ALB, ALPI,
APOA4, APOC2, Apoc3, CA3,
CYP2C8, CYP2C9, CYP3A5,
FABP1, GAL, GUCA2B, MME,
MTTP, MUC2, PNLIPRP1, SCD,
SERPINA1, SERPINB4,
SLC2A2, SLC46A1, VDR
Disorder of blood pressure,
fatty acid metabolism,
inflammation of absolute
anatomical region,
inflammation of organ,
metabolism of terpenoid,
metabolism of vitamin,
synthesis of lipid, transport
of molecule
24 h (KO/WT) 165.333 75 63 ACKR2, BTK, CGAS, DDX58,
DNASE2, DOCK8, FADD, FZD9,
GAPDH, IFIH1, Ifn, IFN Beta, IFN type
1, IFNA1/IFNA13, IFNA2, IFNA4, Ifnar,
IFNAR1, IFNB1, IFNE, IFNG, IFNL1,
IFNL3, IFNL4, IL1B, IL1RN, IL21, IL4,
Interferon alpha, IRF1, IRF3, IRF4,
IRF5, IRF7, JAK, JAK1/2, MAPK1,
MAVS, MYD88, NFATC2, NSD2,
PAF1, PML, PNPT1, PRL, PTGER4,
SAMSN1, SASH1, SOCS1, SP110,
SPI1, STAT1, STAT2, STAT6, TGM2,
TICAM1, TLR3, TLR4, TLR7, TLR9,
TMEM173, TNF, TRIM24
9 CEL, Igtp, ISG15, Mx1, OAS1,
OAS3, Oasl2, RSAD2, ZBP1
Relapsing-remitting multiple
sclerosis, replication of viral
replicon, replication of virus
24 h (KO/WT) 1.000 6 4 IFNB1 4 DHX58, Igtp, Irgm1, STAT1 Quantity of IL-12 in blood
72 h (KO/WT) 10.156 22 6 DNASE2, IKBKG, IL17A, SNCA,
STAT2, TLR3
14 Defb3, DHX58, GBP2, IFIT3,
IL33, IRF7, ISG15, Mx1, OAS2,
OAS3, Oasl2, RSAD2, USP18,
ZBP1
Infection of mammalia, viral
infection
72 h (KO/WT) 4.333 14 4 IFNB1, IKBKG, IL17A, SNCA 9 Defb3, DHX58, GBP2, Igtp, IL33,
IRF7, Irgm1, ISG15, USP18
Infection of mammalia
Regulator effects*: The concept of Regulator Effects in IPA is that The Regulator Effects algorithm connects upstream regulators, dataset molecules, and downstream functions or
diseases affected in your dataset to generate a hypothesis that can explain how the activation or inhibition of an upstream regulator affects the downstream target molecule expression
and the impact of the molecular expression on functions and diseases. The algorithm goes through one or more iterations to merge upstream and downstream results from the Upstream
Regulator. The networks are merged only if the overlap of targets has possible statistical significance (Fisher’s Exact Test p-value of <0.05). For each network, a Consistency Score is
calculated that rewards for paths from regulator->target->disease or function that are consistent. Higher scoring hypotheses are those with more consistent causal paths represented
by a high Consistency Score.
monocytes, neutrophils, and lymphocytes and the development
of gastritis (McGuckin et al., 2007). Analysis of the DE genes
between Muc1−/− vs. WT in response to the infection revealed
significant enrichment of functional clusters that were associated
with antimicrobial and inflammatory responses.
H. pylori infection for 8 h resulted in∼4-fold induction of the
regenerating islet-derived (REG) gene family 1B (Reg1b) mRNA
inMuc1−/− vs. no change inWT gastric tissues (Table 1). REG1B
protein is highly expressed in several human pathologies, such
as inflammatory bowel disease, many of which are associated
with epithelial inflammation (van Beelen Granlund et al., 2013),
indicating that the gastric mucosa of Muc1−/− mice is more
inflamed than WT mice within 8 h of infection. H. pylori
infection for 24 h resulted in ∼2.5-fold induction of mRNA for
Slfn12, a schlafen family member, in Muc1−/− vs. no change
in WT gastric tissues. SLFN12 functions as an inducer of
immune responses and is implicated in enterocyte differentiation
(Table 1).
As infection progressed (24 and 72 h), we observed interferon
gamma (IFNG)- regulated pathways were more strongly
activated in Muc1−/− vs. WT gastric tissues (Z-score 4.12,
P = 1.65-E7, and Z-score 4.96, P = 5.7-E15, respectively,
highlighted in bold in Table 6) characterized by the higher
expression of many proinflammatory genes. Altered genes
included: Cmpk2, Defb3, Duoxa2, Fgg, Gbp2, Gbp3, Gbp4,
Hspa1a/Hspa1b, Ido1, Ifi202b, Ifi44, Ifit1b, Ifit3, Igtp, Irf7, Irgm1,
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TABLE 3 | Gastric Muc1−/− vs. WT (KO/WT) molecule networks* at different time points.
Time Molecules in network Score Focus
molecules
Top diseases and
functions
Sham (KO/WT) ALB, Alphacatenin, AOC1, CDH17, Ces2e, CFD, chymotrypsin, CTRB2, ERK1/2, GAL,
Gm21596/Hmgb1, GOT, H19, Iga, IgG, Igh, Igm, JCHAIN, MTTP, Muc1, MUC13, MUC2,
Muc3, Mucin, PIGR, PRSS3, PTPRZ1, REG3G, Secretase gamma, SLC6A19, TDGF1, TFF3,
UGT, UGT2B28, UGT2B7
53 25 Digestive System
Development and Function,
Humoral Immune
Response, Organ
Development
Sham (KO/WT) 2210010C04Rik, ABCG5, Akt, ALDOB, Apoc3, carboxypeptidase, CPA1, CPA2, CPB1,
CYP2E1, Cyp3a25 (includes others), CYP3A5, DBP, Defa3 (includes others), Defa6, FABP1,
FABP2, Growth hormone, HDL, HDL-cholesterol, hemoglobin, HNF4α dimer, IL23,
LDL-cholesterol, MEP1B, Nr1h, PRAP1, REG3A, SLC13A1, SLC2A2, SLC40A1, SLC5A1,
TM4SF20, trypsin, Trypsinogen
48 23 Carbohydrate Metabolism,
Lipid Metabolism, Small
Molecule Biochemistry
Sham (KO/WT) Ap1, ARG2, CCN3, CELA3B, CG, Collagen type I (complex), Creb, CTRC, CTRL, Defb4,
elastase, ENPP3, GGT1, GJD2, Iglv1, IL1, KLK3, LDL, LYZ, MHC Class II (complex), MME,
Mmp, Mug1/Mug2, NFkB (complex), P38 MAPK, Pro-inflammatory Cytokine, PRSS2, S100G,
Serine Protease, SERPINA1, SERPINB10, SI, TAC1, TCF, Tnf (family)
39 20 Post-Translational
Modification, Protein
Degradation, Protein
Synthesis
8 h (KO/WT) 1810009J06Rik/Gm2663, 2210010C04Rik, carboxypeptidase, chymotrypsin, Collagen type I
(complex), CPA1, CPA2, CPB1, Crisp1/Crisp3, CTRB2, CTRC, CTRL, estrogen receptor,
FABP1, Growth hormone, Iglv1, KLK3, MEP1B, NFkB (complex), PRAP1, Prss1 (includes
others), PRSS2, PRSS3, S100G, Serine Protease, SERPINA1, SI, SLC7A9, TCF, TM4SF20,
Tnf (family), trypsin, Trypsinogen, UXT, VDR
50 24 Post-Translational
Modification, Protein
Degradation, Protein
Synthesis
8 h (KO/WT) ADA, AHSG, Akt, ALB, CELA1, CELA3B, Ces2e, CPS1, Defa3 (includes others), Defa6,
elastase, ENPP3, GOT, hemoglobin, Ige, IgG, Igm, IL12 (complex), LDL, MHC Class II
(complex), Muc1, MUC13, MUC2, Muc3, Mucin, PIGR, SCD, Secretase gamma,
Serpinb3b/Serpinb3c, SLC13A1, SLC40A1, SLC6A19, SLPI, Sos, TFF3
45 22 Cancer, Dermatological
Diseases and Conditions,
Organismal Injury and
Abnormalities
8 h (KO/WT) ABCC2, ALDOB, ALT, AOC1, APOA4, APOC2, Apoc3, ARG2, BHMT, CAR
ligand-CAR-Retinoic acid-RXRα, CDH17, CUZD1, CYP2C8, CYP2C9, CYP2E1, CYP3A5,
ERK1/2, GAL, HDL, HDL-cholesterol, Hnf3, HNF4α dimer, LDL-cholesterol, MAT1A, MTTP,
Ncoa-Nr1i2-Rxra, Ncoa-Nr1i3-Rxra, NCOR-LXR-Oxysterol-RXR-9 cis RA, Nr1h, PXR
ligand-PXR-Retinoic acid-RXRα, Rxr, triacylglycerol lipase, unspecific monooxygenase, VLDL,
VLDL-cholesterol
32 17 Drug Metabolism, Lipid
Metabolism, Small Molecule
Biochemistry
24 h (KO/WT) 2210010C04Rik, 3830403N18Rik/Xlr, ABCC2, Akt, ALDOB, CAR ligand-CAR-Retinoic
acid-RXRα, carboxypeptidase, chymotrypsin, CPA1, CPA2, CPB1, CTRB2, CTRC, CTRL,
CYP2B6, Cyp3a25 (includes others), CYP3A5, FABP1, FABP2, HNF4α dimer, Igtp,
Ncoa-Nr1i2-Rxra, Ncoa-Nr1i3-Rxra, P glycoprotein, PRSS1, Prss1 (includes others), PRSS2,
PRSS3, PXR ligand-PXR-Retinoic acid-RXRα, Rxr, SLC13A1, TMPRSS15, trypsin,
Trypsinogen, TTPA
47 23 Drug Metabolism, Endocrine
System Development and
Function, Lipid Metabolism
24 h (KO/WT) ACE2, Alp, ALPI, ALPP, AMPK, Ap1, APOC2, ARG2, Collagen type I (complex), Collagen(s),
ERK, G6PC, GBP4, Gm10768, Growth hormone, Immunoglobulin, Interferon alpha, LDL,
MEP1B, Mup1 (includes others), Nr1h, Oasl2, PHF11, PRAP1, RNF213, RTP4, S100G, SI,
SLFN12L, Slfn2, SPINK1, STAT1, Tgf beta, TM4SF20, UBE2F
47 23 Developmental Disorder,
Gastrointestinal Disease,
Hereditary Disorder
24 h (KO/WT) 2’ 5’ oas, AOC1, CCL25, CDH17, CUZD1, DHX58, ERK1/2, IDO1, IFI44, IFIT1B, IFIT3, Ifn, IFN
alpha/beta, IFN Beta, IFN type 1, Ifnar, Interferon-α Induced, IRF, IRF7, Irgm1, Isg, ISG15,
ISGF3, JAK1/2, Mx1, Mx2, Oas, OAS1, OAS2, OAS3, RSAD2, Sp100, Stat1-Stat2, TCF, ZBP1
39 20 Antimicrobial Response,
Dermatological Diseases
and Conditions,
Inflammatory Response
72 h (KO/WT) DHX58, ERK1/2, IDO1, Ifi202b, IFI44, IFIT1B, IFIT3, Ifn, IFN alpha/beta, IFN Beta, IFN type 1,
Ifnar, Igtp, Interferon alpha, Interferon-α Induced, IRF, IRF7, Irgm1, Isg, ISG15, ISGF3, JAK,
JAK1/2, Mx1, Mx2, NLRC5, OAS2, OAS3, Oasl2, RSAD2, RTP4, Sp100, TAP1, USP18, ZBP1
50 22 Antimicrobial Response,
Connective Tissue
Disorders, Inflammatory
Response
72 h (KO/WT) 2210010C04Rik, AHSG, Akt, ALB, AMY2B, amylase, carboxypeptidase, CEL, CPA1, CPA2,
CPB1, CTRB2, CTRL, Fibrinogen, GBP2, GBP3, HDL, KNG1, LDL, MHC Class II (complex),
Mug1/Mug2, Nr1h, PNLIP, PNLIPRP1, Pro-inflammatory Cytokine, PRSS2, PRSS3, Pzp,
Serine Protease, SERPINA1, SLFN12L, Tnf (family), triacylglycerol lipase, trypsin, Trypsinogen
47 21 Endocrine System
Disorders, Gastrointestinal
Disease, Immunological
Disease
72 h (KO/WT) 2’ 5’ oas, Apol7e (includes others), Apol9a/Apol9b, APP, beta-estradiol, C2orf49, CELA3B,
CFB, CPA2, CYP2C18, dehydroepiandrosterone sulfate, DGLUCY, DHX58, GBP4, Gm5662
(includes others), GP2, GRIN2A, GSDMC, IFNAR1, IL10RA, IRF1, Mcpt1, Muc1, Mx2,
nitrogen, NR5A2, Oasl2, PPP2CA, RBPJL, RNASE1, Rnu5g, SYCN, Tlr11, Tlr12, TNF
36 17 Cellular Assembly and
Organization, Molecular
Transport, Small Molecule
Biochemistry
Molecule Networks*: Molecule Networks in IPA is that Analysis Ready molecules which interact with other molecules in the Ingenuity Knowledge Base are considered “network eligible”
and serve as “seeds” for generating networks. There may be some Analysis Ready molecules that will pass all the filtering criteria you set for your analysis but may not be network eligible
because there is no known scientific evidence of these molecules directly or indirectly interacting with other molecules in the Ingenuity Knowledge base. The score is a numerical value
used to rank networks according to their degree of relevance to the Network Eligible molecules in your dataset. The score takes into account the number of Network Eligible molecules
in the network and its size, as well as the total number of Network Eligible molecules analyzed and the total number of molecules in the Ingenuity Knowledge Base that could potentially
be included in networks. In the Networks view, networks are ordered according to their score, with the highest scoring network displayed at the top of the page.
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FIGURE 4 | IPA molecular networks analysis of differentially expressed (DE) genes between Muc1−/− vs. wild type gastric tissues before infection. Log ratio fold
changes of DE genes in our data set is shown underneath each gene (- number or green symbol indicates decreased expression and otherwise/red indicates
increased expression).
Isg15, Mx1, Mx2, Nlrc5, Oas2, Oas3, Rsad2, Rtp4, Serpina1,
Slfn12l, Tap1, andUsp18 (Supplementary Table 3). Some of these
genes are controlled by Dnase2, Ikbkg, Il17a, Snca, Stat2, Tlr3
and their induction is associated with suppression of infection
(Table 2 and Figure 8).
Verification of IPA Identified Canonical
Pathways and Networks
To further compare the wild type and Muc1−/− response to
infection, we also performed a sample-to-sample analysis using
Graphia Pro network analysis software, with the filtered set
of 6016 probesets showing at least 1.5-fold difference between
highest and lowest across the eight samples (representing 4,448
unique genes as well as 1,305 unannotated probesets). A Pearson
correlation coefficient threshold of 0.95 was used as it was
the highest value to include all eight samples in the network.
Supplementary Figure 3 shows that the Muc1−/− 24 and 72 h
samples were separated from all other samples on the basis of
gene expression patterns, and that the earlier Muc1−/− samples
were more similar to the wild type 24 and 72 h samples that than
earlier wild type samples. This suggested that there were distinct
gene expression patterns differentiating the response of the
Muc1−/− animals from that of the wild type animals, consistent
with the DE gene analysis. We therefore constructed a GCN
using a Pearson correlation coefficient threshold of 0.87 which
included all 6016 probesets of the filtered list (making 78,064
edges) in the analysis. A summary of the expression patterns of
the largest clusters is shown in Supplementary Table 4 and a full
list of clusters and histograms showing the average expression
pattern of clusters with 10 or more nodes is available in
Supplementary Table 5.
We searched the GCN for known proliferation markers,
mitochondrial genes and protein synthesis genes and found no
indication that these functions were disrupted in the Muc1−/−
response to the infection.
The DE genes described above were concentrated in three
clusters of the GCN. The genes which were upregulated in
the Muc1−/− sham infected animals compared to the wild
type sham infected and also in the wild type at 72 h post
infection compared to the wild type sham infected were
predominantly in Cluster004 (Supplementary Figure 4). Genes
in this cluster showed enrichment of GO terms relating to
digestion, transport, intestinal absorption, microvillus, brush
border membrane. DE genes which were upregulated in 24
and 72 h Muc1−/− samples compared with the corresponding
wild type samples, and some of the genes that were higher
in Muc1−/− at 72 h compared with Muc1−/− sham infected,
were mainly in Cluster005 (Supplementary Figure 4), enriched
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FIGURE 5 | Ingenuity Pathway Analysis (IPA) showing the identified top canonical pathways of differentially expressed genes between Muc1−/− vs. wild type (WT)
gastric tissues in sham or in response to H. pylori infection over time. Significance P-values were calculated based on the Fisher’s right tailed exact test. The-log
(p-value) are shown on the top x-axis of the bar chart. The orange and blue colored bars indicate predicted pathway activation, or predicted inhibition, respectively
(z-score). White bars are those with a z-score at or very close to 0. Gray bars indicate pathways, where no prediction can currently be made. IPA applies
a-log (p-value) cutoff of 1.3 (threshold). SPC, SPINK1 Pancreatic Cancer Pathway; UC, Urea Cycle; NRTAZ, Neuroprotective Role of THOP1 in Alzheimer’s Disease;
MODYS, Maturity Onset Diabetes of Young Signaling; SCM, Superpathway of Citrulline Metabolism; MDI, Melatonin Degradation I; NDIII, Nicotine Degradation III;
SMD, Superpathway of Melatonin Degradation; LXR/RXR, LXR/RXR Activation; FXR/RXR, FXR/RXR Activation; BD, Bupropion Degradation; AD, Acetone
Degradation I (to Methylglyoxal); EB, Estrogen Biosynthesis; SGC, SPINK1 General Cancer Pathway; AICPRR, Activation of IRF by Cytosolic Pattern Recognition
Receptors; INFS, Interferon Signaling; TD, Triacylglycerol Degradation; CS, Coagulation System; APRS, Acute Phase Response Signaling; RB, Retinol Biosynthesis.
for GO terms associated with innate immune response and
response to pathogen. The set of DE genes which were
higher in Muc1−/− 8 h than wild type 8 h, but lower in
Muc1−/− 24 and 72 h compared to the corresponding wild
type time points and also lower in Muc1−/− 72 h compared to
Muc1−/− sham were in Cluster008 (Supplementary Figure 4).
This showed enrichment for GO terms related to catabolism,
digestion and extracellular space. This cluster also included
Spink3, identified as a key regulator by the IPA analysis
(Supplementary Figure 4), and genes encoding many members
of the SPINK1 pathway, including Cela3b, Cpa1, Cpa2, Cpb1,
Ctrc, Ctrl, Prss2, and Prss3 (Supplementary Figure 1). This
cluster also contained a number of other proteases and
protease inhibitors.
Analysis of the expression pattern of Muc1 showed that
the Muc1−/− samples had very low levels of Muc1 mRNA,
as expected. Muc1 was found in Cluster020 where the
average expression across all cluster genes of the Muc1−/−
samples was half that of the wild type and there was no
change during the infection in either WT or Muc1−/−
(Supplementary Figure 4). This cluster contains genes
potentially directly affected by the lack of MUC1, and
includes the Srp54b and Srp54c genes, encoding signal
recognition particles involved in the export of proteins and
both reduced to about 50% of their wild type expression, Rfx6
(regulatory factor X, 6), and sodium channel genes Scn2a
and Scn7a. This cluster was enriched for the GO MF term
receptor regulatory activity and the GO CC terms vesicle and
extracellular region.
In the GCN analysis, Cluster007 showed reduced expression
overall inMuc1−/− compared to wild type sham and also reduced
further as the infection progressed (Supplementary Figure 4).
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TABLE 4 | SPINK1 pancreatic cancer pathway.
Expr log ratio
Symbol Entrez gene name Sham
(KO/WT)
8h (KO/WT) 24h
(KO/WT)
72h
(KO/WT)
WT (8 h/0) WT (24 h/0) WT (72 h/0) KO (8 h/0) KO (24 h/0) KO (72 h/0) Location Type(s)
1810009J06Rik
/Gm2663
Trypsinogen 4 −0.056 1.466 0.098 −0.2 −0.32 0.155 −0.25 1.201 0.309 −0.4 Other Other
2210010C04Rik Trypsinogen 7 1.471 3.431 −3.51 −3.354 −0.83 1.839 −0.23 1.127 −3.14 −5.05 Extracellular space Other
CELA1 Chymotrypsin like
elastase 1
0.836 2.245 −1.95 −0.808 −0.37 1.141 −0.23 1.04 −1.65 −1.87 Extracellular space Peptidase
CELA3B Chymotrypsin like
elastase 3B
1.603 3.467 −3.466 −1.881 −0.46 2.183 0.058 1.403 −2.89 −3.43 Other Peptidase
CPA1 Carboxypeptidase A1 1.363 3.742 −3.94 −3.481 −1.15 1.743 −0.32 1.233 −3.56 −5.16 Extracellular space Peptidase
CPA2 Carboxypeptidase A2 1.888 3.815 −3.898 −2.796 −0.79 2.522 0.277 1.133 −3.26 −4.41 Extracellular space Peptidase
CPB1 Carboxypeptidase B1 1.639 3.857 −3.856 −3.764 −1.21 2.028 −0.05 1.008 −3.47 −5.45 Extracellular space Peptidase
CTRB2 Chymotrypsinogen B2 1.532 3.417 −3.444 −4.267 −0.62 2.177 0.353 1.269 −2.8 −5.45 Cytoplasm Peptidase
CTRC Chymotrypsin C 1.088 2.284 −2.321 −0.605 −0.47 1.236 −0.14 0.723 −2.17 −1.83 Extracellular space Peptidase
CTRL Chymotrypsin like 1.575 3.656 −3.485 −3.223 −0.72 2.125 0.283 1.364 −2.94 −4.51 Extracellular space Peptidase
KLK3 Kallikrein related
peptidase 3
1.102 1.304 −1.047 0.584 0.468 1.084 −0.86 −0.58 −1.07 −1.18 Extracellular space Peptidase
Prss1 (includes
others)
Protease, serine 1
(trypsin 1)
−0.283 1.296 −1.273 0.212 −0.09 0.986 −0.39 1.669 0.152 0.11 Extracellular space Peptidase
PRSS2 Serine protease 2 1.486 3.177 −2.882 −1.491 −0.49 2.044 −0.03 1.197 −2.32 −3.01 Extracellular space Peptidase
PRSS3 Serine protease 3 1.397 3.224 −2.96 −1.316 −0.32 1.654 −0.29 1.503 −2.7 −3.01 Extracellular space Peptidase
Greater than 2 fold changes are highlight; –number in green with green filled indicates decreased expression and otherwise/red indicates increased expression. Number in green indicates decreased expression and red indicates
increased expression.
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FIGURE 6 | Ingenuity Pathway Analysis (IPA) top regulator effect networks analysis of differentially expressed (DE) genes between Muc1−/− vs. wild type gastric
tissues at 8 h H. pylori infection. Log ratio fold changes of DE genes is shown underneath each gene (red color symbol indicates increased expression). Prediction
legend is the same as for Figure 3.
FIGURE 7 | Ingenuity Pathway Analysis regulator effect networks analysis of differentially expressed (DE) genes between Muc1−/− vs. wild type gastric tissues at 8 h
H. pylori infection showed PPARG up-regulated transport of molecule pathway. Log ratio fold changes of DE genes is shown underneath each gene (red color symbol
indicates increased expression). Prediction legend is the same as for Figure 3.
This cluster contained Acta1, encoding smooth muscle actin, as
well as the actin crosslinking protein gene Actn3 and two myosin
genes (Myo1h and Myh2), suggesting that both infection and
Muc1 knockout disrupt the cytoskeleton. The role of H. pylori in
actin rearrangement has been described (Tohidpour et al., 2017)
and this observation warrants further investigation.
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TABLE 5 | Transport molecules.
Expr log ratio
Symbol Entrez gene name Sham
(KO/WT)
8h (KO/WT) 24h
(KO/WT)
72h
(KO/WT)
WT (8 h/0) WT (24 h/0) WT (72 h/0) KO (8 h/0) KO (24 h/0) KO (72 h/0) Location Type(s)
A1CF APOBEC1
complementation
factor
1.347 0.698 −1.079 0.132 0.394 1.555 1.253 −0.378 −0.871 −0.134 Nucleus Other
ABCC2 ATP binding cassette
subfamily C member 2
1.725 2.228 −1.332 −0.11 0.678 1.936 1.631 1.181 −1.122 −0.205 Plasma membrane Transporter
ABCG5 ATP binding cassette
subfamily G member 5
1.371 0.438 −0.871 0.167 0.708 1.321 1.128 −0.225 −0.921 −0.075 Plasma membrane Transporter
ALB Albumin 2.375 3.505 −0.39 3.673 0.071 −0.36 −0.396 1.201 −3.125 0.902 Extracellular space Transporter
Apoc3 Apolipoprotein C–III 1.006 1.144 −0.592 −0.095 0.266 0.968 0.912 0.404 −0.63 −0.189 Extracellular space Transporter
CDH17 Cadherin 17 2.465 1.963 −1.423 −0.191 0.639 2.572 2.432 0.137 −1.316 −0.223 Plasma membrane Transporter
CLCA4 Chloride channel
accessory 4
2.268 1.933 −1.586 −0.171 −0.464 2.362 2.144 0.187 −1.492 −0.442 Plasma membrane Ion channel
Defa3
(includes
others)
Defensin, alpha, 3 2.169 1.852 −0.539 0.925 0.342 1.624 1.615 −0.189 −1.152 0.52 Extracellular space Other
FABP1 Fatty acid binding
protein 1
1.75 1.521 −1.483 0.244 0.102 1.613 1.52 −0.126 −1.619 0.015 Cytoplasm Transporter
FABP2 Fatty acid binding
protein 2
1.492 1.903 −1.491 −0.29 0.032 1.513 1.557 0.444 −1.469 −0.225 Cytoplasm Transporter
GAL Galanin and GMAP
prepropeptide
1.15 1.07 −0.396 −0.221 −0.265 0.879 0.218 −0.346 −0.668 −1.153 Extracellular space Other
GRP Gastrin releasing
peptide
1.312 0.395 −0.562 −0.013 0.216 1.143 0.769 −0.7 −0.731 −0.556 Extracellular space Growth factor
GUCA2B Guanylate cyclase
activator 2B
1.281 1.412 −0.757 −0.231 −0.402 1.132 0.976 −0.272 −0.907 −0.537 Extracellular space Other
MTTP Microsomal triglyceride
transfer protein
2.007 1.583 −1.268 −0.242 0.597 2.024 2.076 0.173 −1.25 −0.173 Cytoplasm Transporter
PIGR Polymeric
immunoglobulin
receptor
1.184 1.073 −0.166 0.283 0.138 0.852 1.143 0.027 −0.498 0.242 Plasma membrane Transporter
SLC13A1 Solute carrier family 13
member 1
2.658 3 −1.167 −0.373 0.124 2.391 2.478 0.466 −1.434 −0.553 Plasma membrane Transporter
SLC22A25 Solute carrier family 22
member 25
1.192 0.586 0.501 0.575 0.473 0.198 0.401 −0.353 −0.656 −0.501 Other Other
SLC26A3 Solute carrier family 26
member 3
2.554 1.924 −1.685 −0.189 0.473 2.415 2.315 −0.157 −1.823 −0.428 Plasma membrane Transporter
SLC2A2 Solute carrier family 2
member 2
1.008 1.556 −0.645 −0.138 0.328 1.118 1.199 0.876 −0.535 0.053 Plasma membrane Transporter
SLC40A1 Solute carrier family 40
member 1
1.099 1.363 −1.16 −0.335 0.176 1.39 1.11 0.441 −0.868 −0.324 Plasma membrane Transporter
SLC5A1 Solute carrier family 5
member 1
1.212 1.814 −0.525 −0.029 0.432 0.995 1.107 1.035 −0.742 −0.134 Plasma membrane Transporter
SLC6A19 Solute carrier family 6
member 19
1.151 1.207 −1.227 −0.405 0.376 1.321 1.11 0.432 −1.058 −0.446 Plasma membrane Transporter
TAC1 Tachykinin precursor 1 1.132 −0.012 −0.687 0.059 0.417 1.136 0.681 −0.727 −0.683 −0.392 Extracellular space Other
ZG16 Zymogen granule
protein 16
1.697 2.714 −2.265 −0.733 −0.141 2.164 1.229 0.876 −1.798 −1.202 Extracellular space Other
Greater than 2 fold changes are highlight; –number in green with green filled indicates decreased expression and otherwise/red indicates increased expression. Number in green indicates decreased expression and red indicates
increased expression.
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TABLE 6 | Gastric Muc1−/− vs. WT (KO/WT) upstream regulators* at different time points.
Time Upstream
regulator
Expr log
ratio
Molecule type Predicted
activation state
Activation
z-score
p-value of
overlap
Sham (KO/WT) HNF4A 0.235 Transcription regulator Activated 3.443 0.00228
8 h (KO/WT) HNF4A 0.075 Transcription regulator Activated 3.477 0.0000242
8 h (KO/WT) HNF1A −0.122 Transcription regulator Activated 3.791 2.62E-10
24 (KO/WT) IRF7 1.178 Transcription regulator Activated 4.874 6.48E-29
24 (KO/WT) Interferon alpha Group Activated 4.386 6.02E-14
24 (KO/WT) IFNG 0.105 Cytokine Activated 4.121 1.65E-07
24 (KO/WT) IRF3 −0.089 Transcription regulator Activated 4.007 6.07E-24
24 (KO/WT) TNF −0.625 Cytokine Activated 3.9 0.00368
24 (KO/WT) IFN Beta Group Activated 3.81 8.62E-16
24 (KO/WT) STAT1 1.008 Transcription regulator Activated 3.982 9.03E-21
72 (KO/WT) IFNG −0.328 Cytokine Activated 4.956 5.7E-15
72 (KO/WT) Interferon alpha Group Activated 4.269 9.96E-18
72 (KO/WT) IFN Beta Group Activated 3.54 3.91E-16
72 (KO/WT) Ifn Group Activated 3.384 4.15E-17
72 (KO/WT) Ifnar Group Activated 3.937 1.37E-22
72 (KO/WT) STAT1 0.834 Transcription regulator Activated 4.233 1.83E-24
72 (KO/WT) IL21 0.094 Cytokine Activated 3.606 3.41E-14
72 (KO/WT) APP 0.143 Other Activated 3.484 2.7E-07
72 (KO/WT) IRF7 1.119 Transcription regulator Activated 4.794 1.32E-33
72 (KO/WT) TLR9 0.095 Transmembrane
receptor
Activated 3.341 1.24E-12
72 (KO/WT) IRF3 0.291 Transcription regulator Activated 4.383 1.07E-24
72 (KO/WT) IFNB1 0.126 Cytokine Activated 3.65 7.79E-21
72 (KO/WT) IFNA2 Cytokine Activated 3.772 1.11E-15
72 (KO/WT) TLR3 0.306 Transmembrane
receptor
Activated 3.526 2.21E-16
24 (KO/WT) ACKR2 0.246 G-protein coupled
receptor
Inhibited −3.606 9.71E-19
24 (KO/WT) IL4 −0.108 Cytokine Inhibited −3.861 6.65E-08
24 (KO/WT) SOCS1 0.136 Other Inhibited −3.41 1.73E-12
24 (KO/WT) PTGER4 0.021 G-protein coupled
receptor
Inhibited −3.729 1.41E-12
24 (KO/WT) TRIM24 −0.025 Transcription regulator Inhibited −3.627 2.93E-19
24 (KO/WT) SIRT1 −0.335 Transcription regulator Inhibited −3.838 6.84E-19
24 (KO/WT) PNPT1 0.491 Enzyme Inhibited −4.123 5.54E-25
72 (KO/WT) ACKR2 0.188 G-protein coupled
receptor
Inhibited −3.317 8.73E-18
72 (KO/WT) PTGER4 −0.141 G-protein coupled
receptor
Inhibited −3.44 5.67E-13
72 (KO/WT) TRIM24 −0.032 Transcription regulator Inhibited −3.978 1.06E-21
72 (KO/WT) SIRT1 0.232 Transcription regulator Inhibited −4.243 2.51E-17
72 (KO/WT) PNPT1 0.315 Enzyme Inhibited −3.873 6.15E-25
Upstream Regulators*: Use IPA Upstream Regulator Analysis to identify the upstream regulators that may be responsible for gene expression changes observed in your experimental
dataset. IPA predicts which upstream regulators are activated or inhibited to explain the up-regulated and down-regulated genes observed in your dataset. Knowledge of this regulatory
cascade can help you understand the biological activities occurring in the tissues or cells that you are studying. IPA uses a z-score algorithm to make predictions. The z-score algorithm
is designed to reduce the chance that random data will generate significant predictions.
Selected DE Genes From Diverse Gene
Ontologies Showed Consistent Trends in
RT-qPCR Assay
Several genes identified as highly DE at one or more
time-points over 72 h based on microarray analysis and
which were also part of significantly altered pathways and
networks identified by IPA were independently validated
by RT-qPCR (Figure 9). Overall, most genes measured by
qPCR confirmed the changes in gene expression identified by
microarray (Figure 9).
DISCUSSION
In this study we first identified a specific set of MUC1-regulated
gastric genes by performing microarray analysis of the gastric
transcriptome of Muc1 knockout mice under physiological
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FIGURE 8 | Ingenuity Pathway Analysis regulator effect networks analysis of differentially expressed (DE) genes between Muc1−/− vs. wild type gastric tissues at 72 h
H. pylori infection. Log ratio fold changes of DE genes in our data set is shown underneath each gene (red color symbol indicates increased expression). Prediction
legend is the same as for Figure 3.
FIGURE 9 | RT qPCR validation of transcripts selected as the most highly differentially expressed genes between Muc1−/− vs. wild type (WT) gastric tissues.
Statistics: Ordinary one-way ANOVA corrected for multiple comparisons by controlling the False Discovery Rate (FDR) using “Two-stage step-up method of Benjamini,
Krieger, and Yekutieli;” n = 3, * vs. WT at each time point, *P < 0.05, **P < 0.01, ***P < 0.001).
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conditions. Gene categorization analysis (using both IPA and GO
term enrichment) indicated that in the uninfected state MUC1-
associated genes are involved in a wide range of cellular functions,
with the most highly impacted network related to lipid transport
and regulated via the transcription factors HINF1A, HINF4A,
and SOX2 (Figures 3, 4). The Sry-containing protein SOX2
was initially shown to regulate the self-renewal of mouse and
human embryonic stem cells (ESCs) and controls the formation
of several cell types during fetal development, such as anterior
foregut endoderm (Que et al., 2007). SOX2 is also important for
the maintenance of stem cells in multiple adult tissues, and it
is one of the key transcription factors for establishing induced
pluripotent stem cells (Boyer et al., 2005). SOX2 has been shown
to bind the MUC1 promoter in human embryonic stem cells
(Boyer et al., 2005). In cancer cells, MUC1 has been shown to
drive self-renewal capacity and promote stemness of cancer cells.
Targeting the MUC1 cytoplasmic domain (MUC1-C) genetically
or pharmacologically decreased: (i) expression of breast cancer
stem cell markers including SOX2 (Hata et al., 2019); and (ii)
lung cancer stem cell generation associated with decreased levels
of SOX2 (Ham et al., 2016). Our study further demonstrates that
MUC1 deficiency decreases the expression of Sox2 in normal
gastric tissue. Further studies will now be needed to define how
Muc1 influences Sox2 expression.
Knowledge of the gastric microbiota is evolving, and it
is now appreciated that the stomach supports a bacterial
community with possibly hundreds of bacterial species that
influence stomach homeostasis (Sheh and Fox, 2013). Most of
these microbial residents will grow within the mucus layer that
overlies the gut epithelium. The mucus layer in the stomach
consists of a cell-associated layer (predominantly MUC1) and
secreted mucins (mainly MUC5AC) (McGuckin et al., 2011).
Recent studies showed that the maturation and function of the
mucus layer are strongly influenced by the gut microbiota. In
turn, the glycan repertoire of mucins can select for distinct
mucosa-associated bacteria that are able to bind or degrade
specific mucin glycans as a nutrient source (Schroeder, 2019).
It is likely that gastric microbial ecosystems will differ between
Muc1−/− and WT mice. Alterations in the mucosa-associated
microbiota could impact on host nutrient metabolism, thus
explaining the higher expression of lipid transporter genes in
Muc1−/− gastric tissue. MUC1 has also previously been shown
to be a metabolic master regulator in cancer cells in which
it regulated metabolism flux at multiple levels, including: (i)
directly regulating expression of metabolic genes by acting as
co-transcriptional factor; (ii) regulating metabolic functions by
modulating the activity/stability of enzymes and transcription
factors; and (iii) modulating levels of reactive oxygen species and
metabolite flux (Pitroda et al., 2009; Mehla and Singh, 2014).
For example, MUC1-C has been shown to regulate glycolysis
by directly modulating the functions of the metabolic enzyme,
pyruvate kinase M2 (Kosugi et al., 2011). Our results suggest
that MUC1 also modulates epithelial metabolic function in the
normal gastric mucosa with potential importance in both health
and during mucosal infection.
In addition to providing the first-line defensive barrier
against many pathogens, gastric mucus also protects the gastric
mucosa from enzymatic autodigestion (e.g., by pepsin) and from
erosion by acid, premature trypsinogen activation, and from
ingested caustic materials. An intriguing and novel finding of
MUC1 deficiency under physiological conditions is the inhibition
of the SPINK pancreatic cancer pathway. SPINK1 or its
homologous protein SPINK3 in mouse, originally isolated from
the pancreas as an inhibitor of trypsin, is present throughout
the gastrointestinal tract (with stomach having the 2nd highest
expression behind pancreas) (Marchbank et al., 1996), and it
is the only protease inhibitor known to be secreted into the
intestinal lumen. SPINK1 functions as an inhibitor of serine-
proteinases, including trypsin, that prevents excessive digestion
of the mucus by luminal proteases within the stomach and
colon (Marchbank et al., 1996). The inhibition of this pathway
in Muc1−/− mice might result in a thinner mucus layer due
to the high uninhibited serine proteinase activity, and thereby
predispose to increased penetration by H. pylori. This mucus
defect could explain the∼10-fold higherH. pylori colonization in
Muc1−/− mice compared with WT mice very early in infection
at a time when innate responses to the bacteria would only be
in the preliminary stages of activation and unlikely to impact
on bacterial survival or replication. H. pylori secretes a serine
protease, HtrA, that is involved in gastric colonization and
pathogenesis (Zarzecka et al., 2019), and another possibility
is that SPINK1 inhibits this protease and MUC1 deficiency-
induced reduction of SPINK1 also enhances HtrA activity and
pathogenesis. In addition, SPINK1 has been shown to accelerate
the healing of stress-induced gastric lesions by inhibiting gastric
acid and pepsin outputs in rats (Konturek et al., 1998). The
greater bacterial burden in the MUC1-deficient mice continued
at 24–72 h of infection, and we observe this pathway to be
potently activated at 24 and 72 h of infection in the gastric
tissue of Muc1−/− mice compared with WT mice. The higher
bacterial burden could cause more tissue damage in the gastric
mucosa of Muc1−/− mice compared with WT mice, thus the
activation of this pathway is likely to stimulate repair at sites of
infection and epithelial injury inMuc1−/− mice. Induction of the
pathway could also represent a feedback loop to prevent further
damage of mucus due to the higher colonization of H. pylori. We
previously have demonstrated that both epithelial and leucocyte
MUC1 mucin protect against H. pylori pathogenesis in mice
by limiting pathogen contact with the host epithelium and by
limiting activation of the NLRP3 inflammasome in macrophages,
respectively. We now show that MUC1 may also limit H. pylori
penetration by protecting mucus from enzymatic autodigestion.
Together these findings suggest that MUC1 protects the host
against pathogens via multiple distinct mechanisms involving
multiple cell types.
The time course analysis of this study showed the
induction of a potent anti-pathogen response within 24 h
of H. pylori infection, with infection in Muc1−/− mice
characterized by higher induction of INFG-regulated target
genes (Supplementary Table 3). For instance, we observed
that the genes encoding interferon induced protein 44 (Ifi44
gene) and schlafen family member 12 like (Slfn12l gene) are
two of the most highly induced genes in Muc1−/− mice vs.
WT at 24 h post-infection. IFI44, was associated with multiple
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different viral infections (Honda et al., 1990; Bochkov et al.,
2010; Kaczkowski et al., 2012), and has been shown to induce an
antiproliferative state in cells (Hallen et al., 2007). SLFN12L also
functions as a regulator of cell proliferation and differentiation,
and in the induction of immune responses (Mavrommatis
et al., 2013). This finding suggested that there are more infected
epithelial cells in the gastric mucosa of Muc1−/− mice, and
consequently a more robust response from the host to try to
limit the infection by increased expression of immune response
and antiproliferation genes and a higher IFNG-modulated
anti-pathogen response. A higher number of infected cells is
consistent with the higher H. pylori colonization in the gastric
mucosa ofMuc1−/−mice throughout the first 3 days of infection.
These data suggested that MUC1 has an anti-infection and anti-
inflammatory function in response to H. pylori infection, which
is consistent with our previous finding that MUC1 suppresses
inflammation in response to H. pylori infection in vitro and in
vivo (McGuckin et al., 2007; Linden et al., 2009; Sheng et al.,
2013) via negative regulation of NF-κB (Guang et al., 2010;
Sheng et al., 2013) and the NLRP3 inflammasome (Ng et al.,
2016).
A sample-to-sample network of all samples in the analysis
showed that the Muc1−/− 24 and 72 h samples were separated
from all others, indicating that they were substantially different
from both the earlier Muc1−/−samples and the same time
points in WT. In addition, sham and 8 h infected Muc1−/−
samples were more similar to the WT 24 and 72 h infection
samples than the earlier time points in WT. This association
was substantiated by the GCN analysis which revealed clusters
of genes in which expression patterns were distinct in Muc1−/−
mice at 24 and 72 h infection, and Muc1−/− sham and 8 h
expression was similar to WT 24 and 72 h expression. These
results suggest that Muc1−/−animals are poised to respond
to the early stages of the infection, although by 72 h they
are very different from the WT. These data highlight the
importance ofMUC1 for restriction of earlyH. pylori infection by
alterations in the molecular network providing mucosal defense
against infection.
In conclusion, we have reported a global overview of MUC1-
regulated genes in response toH. pylori infection, it likely reflects
the subsequent defensive response although this needs to be
verified at the proteomic level.
DATA AVAILABILITY STATEMENT
The original contributions presented in the study are publicly
available. This data can be found here: https://www.ncbi.nlm.nih.
gov/geo/query/acc.cgi?acc=GSE151418.
ETHICS STATEMENT
The animal study was reviewed and approved by The
University of Melbourne Animal Ethics Committee approval
(AEEC No. 06205).
AUTHOR CONTRIBUTIONS
YS designed, performed and analyzed mouse, RNA extraction,
microarray and QPCR experiments, and wrote the manuscript.
GN and AE designed, performed, and analyzed mouse
experiments. GP designed, performed, and analyzed microarray
experiments. KS performed the GCN analysis. SH provided
intellectual input to the experimental design and analysis. PS
provided intellectual input to the project including experimental
design, detailed comments, and suggestions on drafts of the
manuscript. MM supervised the project, provided intellectual
input to experimental planning and analysis, was involved
in writing, and was responsible for the final version of the
manuscript. All authors contributed to the article and approved
the submitted version.
SUPPLEMENTARY MATERIAL
The Supplementary Material for this article can be found
online at: https://www.frontiersin.org/articles/10.3389/fcimb.
2020.00343/full#supplementary-material
REFERENCES
Bochkov, Y. A., Hanson, K. M., Keles, S., Brockman-Schneider, R. A., Jarjour, N.
N., and Gern, J. E. (2010). Rhinovirus-induced modulation of gene expression
in bronchial epithelial cells from subjects with asthma. Mucosal Immunol. 3,
69–80. doi: 10.1038/mi.2009.109
Boyer, L. A., Lee, T. I., Cole, M. F., Johnstone, S. E., Levine, S. S., Zucker, J. P.,
et al. (2005). Core transcriptional regulatory circuitry in human embryonic
stem cells. Cell 122, 947–956. doi: 10.1016/j.cell.2005.08.020
Calvano, S. E., Xiao, W., Richards, D. R., Felciano, R. M., Baker, H. V., Cho, R. J.,
et al. (2005). A network-based analysis of systemic inflammation in humans.
Nature 437, 1032–1037. doi: 10.1038/nature03985
Carvalho, F., Seruca, R., David, L., Amorim, A., Seixas, M., Bennett, E., et al.
(1997). MUC1 gene polymorphism and gastric cancer–an epidemiological
study. Glycoconj J. 14, 107–111. doi: 10.1023/A:1018573201347
Chang, J. T., and Nevins, J. R. (2006). GATHER: a systems approach
to interpreting genomic signatures. Bioinformatics 22, 2926–2933.
doi: 10.1093/bioinformatics/btl483
Guang, W., Ding, H., Czinn, S. J., Kim, K. C., Blanchard, T. G., and Lillehoj,
E. P. (2010). Muc1 cell surface mucin attenuates epithelial inflammation in
response to a common mucosal pathogen. J. Biol. Chem. 285, 20547–20557.
doi: 10.1074/jbc.M110.121319
Hallen, L. C., Burki, Y., Ebeling, M., Broger, C., Siegrist, F., Oroszlan-
Szovik, K., et al. (2007). Antiproliferative activity of the human IFN-
alpha-inducible protein IFI44. J. Interferon Cytokine Res. 27, 675–680.
doi: 10.1089/jir.2007.0021
Ham, S. Y., Kwon, T., Bak, Y., Yu, J. H., Hong, J., Lee, S. K., et al. (2016).
Mucin 1-mediated chemo-resistance in lung cancer cells. Oncogenesis 5:e185.
doi: 10.1038/oncsis.2015.47
Hata, T., Rajabi, H., Yamamoto, M., Jin, C., Ahmad, R., Zhang, Y., et al. (2019).
Targeting MUC1-C inhibits TWIST1 signaling in triple-negative breast cancer.
Mol. Cancer Ther. 18, 1744–1754. doi: 10.1158/1535-7163.MCT-19-0156
Honda, Y., Kondo, J., Maeda, T., Yoshiyama, Y., Yamada, E., Shimizu, Y.
K., et al. (1990). Isolation and purification of a non-A, non-B hepatitis-
associated microtubular aggregates protein. J. Gen. Virol. 71(Pt 9), 1999–2004.
doi: 10.1099/0022-1317-71-9-1999
Frontiers in Cellular and Infection Microbiology | www.frontiersin.org 18 July 2020 | Volume 10 | Article 343
Sheng et al. Muc1-modulated Gene Expression in Infection
Huang da, W., Sherman, B. T., and Lempicki, R. A. (2009a). Bioinformatics
enrichment tools: paths toward the comprehensive functional analysis of large
gene lists. Nucleic Acids Res. 37, 1–13. doi: 10.1093/nar/gkn923
Huang da, W., Sherman, B. T., and Lempicki, R. A. (2009b). Systematic and
integrative analysis of large gene lists using DAVID bioinformatics resources.
Nat. Protoc. 4, 44–57. doi: 10.1038/nprot.2008.211
Kaczkowski, B., Rossing, M., Andersen, D. K., Dreher, A., Morevati, M., Visser,
M. A., et al. (2012). Integrative analyses reveal novel strategies in HPV11,-16
and−45 early infection. Sci. Rep. 2:515. doi: 10.1038/srep00515
Konturek, P., Brzozowski, T., Konturek, S. J., Taut, A., Pierzchalski, P., Elia, G.,
et al. (1998). Base variant of human pancreatic secretory trypsin inhibitor
in healing of stress-induced gastric lesions in rats. Regul. Pept. 77, 95–103.
doi: 10.1016/S0167-0115(98)00105-0
Kosugi, M., Ahmad, R., Alam, M., Uchida, Y., and Kufe, D. (2011). MUC1-C
oncoprotein regulates glycolysis and pyruvate kinaseM2 activity in cancer cells.
PLoS ONE 6:e28234. doi: 10.1371/journal.pone.0028234
Lee, A., O’Rourke, J., De Ungria, M. C., Robertson, B., Daskalopoulos, G., and
Dixon, M. F. (1997). A standardized mouse model of Helicobacter pylori
infection: introducing the Sydney strain. Gastroenterology 112, 1386–1397.
doi: 10.1016/S0016-5085(97)70155-0
Linden, S. K., Sheng, Y. H., Every, A. L., Miles, K. M., Skoog, E. C., Florin, T.
H., et al. (2009). MUC1 limits Helicobacter pylori infection both by steric
hindrance and by acting as a releasable decoy. PLoS Pathog. 5:e1000617.
doi: 10.1371/journal.ppat.1000617
Marchbank, T., Chinery, R., Hanby, A. M., Poulsom, R., Elia, G., and Playford, R.
J. (1996). Distribution and expression of pancreatic secretory trypsin inhibitor
and its possible role in epithelial restitution. Am. J. Pathol. 148, 715–722.
Marchbank, T., Freeman, T. C., and Playford, R. J. (1998). Human pancreatic
secretory trypsin inhibitor. Distribution, actions and possible role in mucosal
integrity and repair. Digestion 59, 167–174. doi: 10.1159/000007485
Mavrommatis, E., Fish, E. N., and Platanias, L. C. (2013). The schlafen family
of proteins and their regulation by interferons. J. Interferon Cytokine Res. 33,
206–210. doi: 10.1089/jir.2012.0133
McGuckin,M. A., Every, A. L., Skene, C. D., Linden, S. K., Chionh, Y. T., Swierczak,
A., et al. (2007). Muc1 mucin limits both Helicobacter pylori colonization
of the murine gastric mucosa and associated gastritis. Gastroenterology 133,
1210–1218. doi: 10.1053/j.gastro.2007.07.003
McGuckin, M. A., Linden, S. K., Sutton, P., and Florin, T. H. (2011).
Mucin dynamics and enteric pathogens. Nat. Rev. Microbiol. 9, 265–278.
doi: 10.1038/nrmicro2538
Mehla, K., and Singh, P. K. (2014). MUC1: a novel metabolic master regulator.
Biochim. Biophys. Acta 1845, 126–135. doi: 10.1016/j.bbcan.2014.01.001
Mi, H., Muruganujan, A., Ebert, D., Huang, X., and Thomas, P. D. (2019a).
PANTHER version 14: more genomes, a new PANTHER GO-slim and
improvements in enrichment analysis tools. Nucleic Acids Res. 47, D419–D426.
doi: 10.1093/nar/gky1038
Mi, H., Muruganujan, A., Huang, X., Ebert, D., Mills, C., Guo, X., et al.
(2019b). Protocol Update for large-scale genome and gene function analysis
with the PANTHER classification system (v.14.0). Nat. Protoc. 14, 703–721.
doi: 10.1038/s41596-019-0128-8
Ng, G. Z., Menheniott, T. R., Every, A. L., Stent, A., Judd, L. M., Chionh, Y. T., et al.
(2016). The MUC1 mucin protects against Helicobacter pylori pathogenesis
in mice by regulation of the NLRP3 inflammasome. Gut 65, 1087–1099.
doi: 10.1136/gutjnl-2014-307175
Pitroda, S. P., Khodarev, N. N., Beckett, M. A., Kufe, D. W., andWeichselbaum, R.
R. (2009). MUC1-induced alterations in a lipid metabolic gene network predict
response of human breast cancers to tamoxifen treatment. Proc. Natl. Acad. Sci.
U.S.A. 106, 5837–5841. doi: 10.1073/pnas.0812029106
Que, J., Okubo, T., Goldenring, J. R., Nam, K. T., Kurotani, R., Morrisey, E. E.,
et al. (2007). Multiple dose-dependent roles for Sox2 in the patterning and
differentiation of anterior foregut endoderm. Development 134, 2521–2531.
doi: 10.1242/dev.003855
Rawla, P., and Barsouk, A. (2019). Epidemiology of gastric cancer: global
trends, risk factors and prevention. Prz Gastroenterol. 14, 26–38.
doi: 10.5114/pg.2018.80001
Schroeder, B. O. (2019). Fight them or feed them: how the intestinal
mucus layer manages the gut microbiota. Gastroenterol. Rep. 7, 3–12.
doi: 10.1093/gastro/goy052
Sheh, A., and Fox, J. G. (2013). The role of the gastrointestinal microbiome
in Helicobacter pylori pathogenesis. Gut Microbes 4, 505–531.
doi: 10.4161/gmic.26205
Sheng, Y. H., Hasnain, S. Z., Florin, T. H., and McGuckin, M. A. (2012). Mucins
in inflammatory bowel diseases and colorectal cancer. J. Gastroenterol. Hepatol.
27, 28–38. doi: 10.1111/j.1440-1746.2011.06909.x
Sheng, Y. H., Triyana, S., Wang, R., Das, I., Gerloff, K., Florin, T. H., et al.
(2013). MUC1 and MUC13 differentially regulate epithelial inflammation
in response to inflammatory and infectious stimuli. Mucosal Immunol. 6,
557–568. doi: 10.1038/mi.2012.98
Spicer, A. P., Rowse, G. J., Lidner, T. K., and Gendler, S. J. (1995). Delayed
mammary tumor progression in Muc-1 null mice. J. Biol. Chem. 270,
30093–30101. doi: 10.1074/jbc.270.50.30093
Sutton, P., Wilson, J., and Lee, A. (2000). Further development of the
Helicobacter pylori mouse vaccination model. Vaccine 18, 2677–2685.
doi: 10.1016/S0264-410X(00)00052-9
Theocharidis, A., van Dongen, S., Enright, A. J., and Freeman, T. C.
(2009). Network visualization and analysis of gene expression data using
BioLayout Express(3D). Nat. Protoc. 4, 1535–1550. doi: 10.1038/nprot.
2009.177
Tohidpour, A., Gorrell, R. J., Roujeinikova, A., and Kwok, T. (2017). The
middle fragment of Helicobacter pylori CagA induces actin rearrangement
and triggers its own uptake into gastric epithelial cells. Toxins 9:237.
doi: 10.3390/toxins9080237
van Beelen Granlund, A., Ostvik, A. E., Brenna, O., Torp, S. H., Gustafsson, B.
I., and Sandvik, A. K. (2013). REG gene expression in inflamed and healthy
colon mucosa explored by in situ hybridisation. Cell Tissue Res. 352, 639–646.
doi: 10.1007/s00441-013-1592-z
van Dongen, S., and Abreu-Goodger, C. (2012). Using MCL to
extract clusters from networks. Methods Mol. Biol. 804, 281–295.
doi: 10.1007/978-1-61779-361-5_15
Vinall, L. E., King, M., Novelli, M., Green, C. A., Daniels, G., Hilkens, J.,
et al. (2002). Altered expression and allelic association of the hypervariable
membrane mucin MUC1 in Helicobacter pylori gastritis. Gastroenterology 123,
41–49. doi: 10.1053/gast.2002.34157
Wang, G. P., and Xu, C. S. (2010). Pancreatic secretory trypsin inhibitor:
more than a trypsin inhibitor. World J. Gastrointest Pathophysiol. 1, 85–90.
doi: 10.4291/wjgp.v1.i2.85
Wolfe, C. J., Kohane, I. S., and Butte, A. J. (2005). Systematic survey reveals general
applicability of “guilt-by-association” within gene coexpression networks. BMC
Bioinformatics 6:227. doi: 10.1186/1471-2105-6-227
Wykes, M., MacDonald, K. P., Tran, M., Quin, R. J., Xing, P. X., Gendler,
S. J., et al. (2002). MUC1 epithelial mucin (CD227) is expressed by
activated dendritic cells. J. Leukoc. Biol. 72, 692–701. doi: 10.1189/jlb.72.
4.692
Zarzecka, U., Modrak-Wojcik, A., Figaj, D., Apanowicz, M., Lesner, A.,
Bzowska, A., et al. (2019). Properties of the HtrA protease from bacterium
Helicobacter pylori whose activity is indispensable for growth under
stress conditions. Front. Microbiol. 10:961. doi: 10.3389/fmicb.2019.
00961
Conflict of Interest: The authors declare that the research was conducted in the
absence of any commercial or financial relationships that could be construed as a
potential conflict of interest.
Copyright © 2020 Sheng, Ng, Summers, Every, Price, Hasnain, Sutton and
McGuckin. This is an open-access article distributed under the terms of the Creative
Commons Attribution License (CC BY). The use, distribution or reproduction in
other forums is permitted, provided the original author(s) and the copyright owner(s)
are credited and that the original publication in this journal is cited, in accordance
with accepted academic practice. No use, distribution or reproduction is permitted
which does not comply with these terms.
Frontiers in Cellular and Infection Microbiology | www.frontiersin.org 19 July 2020 | Volume 10 | Article 343
